🏛️ Verified NIH Record • Updated 2026-08-21
Vitamin A Supplementation in Allogeneic Stem Cell Transplantation. (NCT06450925)
A Randomized Double Blinded Trial of Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
🟢 Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: Children's Hospital Medical Center, Cincinnati
🩺 Plain-English Summary (8th-Grade Level)
The investigators hypothesize that single oral high dose supplementation with vitamin A will reduce the incidence of moderate-severe chronic graft-versus-host disease (GVHD) compared with placebo.
Who can join: Review the eligibility criteria below.
Location: Moffitt Cancer Center — Tampa, Florida
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Moffitt Cancer Center — Tampa, Florida
- Roswell Park Comprehensive Cancer Center — Buffalo, New York
- The Ohio State University — Columbus, Ohio
📞 Contact the Study Coordinator
Phone: (513) 636-7679
Email: celeste.dourson@cchmc.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Graft Vs Host Disease
- Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD — New York, New York
- A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease — Toronto, Ontario
- Horizons Chronic Graft-Versus-Host-Disease Study — Miami, Florida
- Pediatric cGVHD Symptom Scale — Phoenix, Arizona
- Chronic GVHD Response Measures Validation — Seattle, Washington
- A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant — San Francisco, California
Explore by condition: All Graft Vs Host Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.